Smart diagnostics: Sustainable and fair diagnostics and treatment of wrist ligament injuries with CTMA Technology; An international collaborative project
Reference number | |
Coordinator | Region Örebro Län - Ortopediska Kliniken, Universitetssjukhuset Örebro |
Funding from Vinnova | SEK 580 000 |
Project duration | August 2025 - August 2027 |
Status | Ongoing |
Venture | Medtech4Health innovators |
Call | Medtech4Health: Implementation of medical technology in healthcare in 2025 |
Purpose and goal
The purpose of the project is to develop and validate a new, non-invasive diagnostic method – CT-based motion analysis (CTMA) – for detecting and assessing injuries to the TFCC ligament in the wrist. The goal is to enable earlier and more reliable diagnosis, reducing the need for invasive arthroscopy, improving treatment decisions, minimizing the risk of long-term complications, and ultimately enhancing quality of life for patients with wrist injuries.
Expected effects and result
Expected outcomes include the validation of CTMA as a safe and reliable non-invasive method for diagnosing TFCC injuries in the wrist. The method is anticipated to improve diagnostic accuracy, enabling faster and more targeted treatment. Effects include reduced need for invasive procedures, better patient outcomes, increased access to advanced diagnostics beyond specialist centers, and strengthened international competitiveness of Swedish medical technology.
Planned approach and implementation
The project is divided into three phases. First, a systematic review of a large arthroscopic patient registry will identify eligible cases. Next, two clinical studies will be conducted to evaluate CTMA against nanoscopic validation in both acute and chronic TFCC injuries. In the final phase, results will be analyzed, scientific papers published, and the method implemented in clinical routines, with the goal of scaling the technology nationally and internationally.